Company intelligence / Profile preview

MEMetic

Los Angeles, California, United Statesmemeticarts.com ↗

Ownership: Private
Development stage: Other

Overview

The company has launched functional beverages using its proprietary liposome-based delivery system. Clinical studies with Huntington Medical Research Institute showed that their system enables nearly 90% absorption of DHA/EPA—comparable to natural sources like salmon and significantly better than traditional gel caps[1].

Therapeutic areas: NeurologyCardiovascular
Modalities: Liposomal delivery technology
Industry: Non-Drug Biotech

Partnerships

Huntington Medical Research Institute (clinical validation partner)

Beyond the preview

Go deeper on MEMetic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEMetic.

Explore the full profile